Organization
Global Biometric Sciences, Bristol-Myers Squibb, Princeton, United States
2 abstracts
Abstract
A FIRST-IN-HUMAN, STUDY OF BMS-986165, A SELECTIVE, POTENT, ALLOSTERIC SMALL MOLECULE INHIBITOR OF TYROSINE KINASE 2 Org: Innovative Clinical Development, Clinical Pharmacology and Toxicology Department, Global Biometric Sciences, Bristol-Myers Squibb, Princeton, United States,
Abstract
ABATACEPT SUSTAINS INHIBITION OF RADIOGRAPHIC PROGRESSION OVER 2 YEARS IN RHEUMATOID ARTHRITIS (RA) PATIENTS WITH AN INADEQUATE RESPONSE TO METHOTREXATE (MTX): RESULTS FROM THE LONG-TERM EXTENSION (LTE) OF THE AIM TRIALOrg: SYNARC, Global Biometric Sciences, Bristol-Myers Squibb, Princeton, United States, Bristol-Myers Squibb, Albany Medical College,